ALEXANDRA SMITH: Open Payments
NPI 1871948992 · TYLER, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$46,509 in 263 payments from 15 companies in 2025. Trend: 2023 $7,243 · 2024 $11,339 · 2025 $46,509
Speaker / faculty: $31,643Travel & lodging: $9,054Food & beverage: $5,501Consulting: $200Education: $111
| Company | Payments | Amount |
|---|---|---|
| Teva Pharmaceuticals USA, Inc. | 108 | $29,224 |
| Otsuka America Pharmaceutical, Inc. | 43 | $15,128 |
| Neurocrine BioSciences, Inc. | 19 | $419 |
| Vanda Pharmaceuticals Inc. | 14 | $403 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 14 | $276 |
| E.R. Squibb & Sons, L.L.C. | 16 | $251 |
| Lundbeck LLC | 14 | $246 |
| Alkermes, Inc. | 16 | $233 |
| ABBVIE INC. | 11 | $145 |
| Janssen Scientific Affairs, LLC | 1 | $60 |
Products named: UZEDY, ABILIFY MAINTENA, INGREZZA, FANAPT, AUSTEDO XR, CAPLYTA, COBENFY, ARISTADA.
Industry payments across TX — which companies pay providers there.
